Abstract
During the past years suicide statistics in Germany showed a dramatic decrease of suicide rates. Such a reduction in a comparatively short time period is not explainable by an altered frequency of major psychiatric disorders or certain neurobiological conditions that may underlie suicide; other factors causing or leading to suicide and their modification have to be considered. This overview illustrates various risk factors for suicide different from neurobiology. Epidemiological aspects and the effect of political, social and economic contributions to suicide rates are exemplified. With regard to the incidence of major psychiatric disorders the paper focuses on physical illnesses and their risk of suicide. Finally the significance of changes in the accessibility of suicide methods is discussed.
Keywords: Age, pain, physical illness, psychiatric disorders, suicide, suicide methods, unemployment.
CNS & Neurological Disorders - Drug Targets
Title:Risk Factors for Suicide – An Alternative View
Volume: 12 Issue: 7
Author(s): Tim Johannes Krause, Bernhard Bogerts and Axel Genz
Affiliation:
Keywords: Age, pain, physical illness, psychiatric disorders, suicide, suicide methods, unemployment.
Abstract: During the past years suicide statistics in Germany showed a dramatic decrease of suicide rates. Such a reduction in a comparatively short time period is not explainable by an altered frequency of major psychiatric disorders or certain neurobiological conditions that may underlie suicide; other factors causing or leading to suicide and their modification have to be considered. This overview illustrates various risk factors for suicide different from neurobiology. Epidemiological aspects and the effect of political, social and economic contributions to suicide rates are exemplified. With regard to the incidence of major psychiatric disorders the paper focuses on physical illnesses and their risk of suicide. Finally the significance of changes in the accessibility of suicide methods is discussed.
Export Options
About this article
Cite this article as:
Krause Johannes Tim, Bogerts Bernhard and Genz Axel, Risk Factors for Suicide – An Alternative View, CNS & Neurological Disorders - Drug Targets 2013; 12 (7) . https://dx.doi.org/10.2174/18715273113129990096
DOI https://dx.doi.org/10.2174/18715273113129990096 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Current Pharmaceutical Design Alcoholisms Evolutionary and Cultural Origins
Current Drug Abuse Reviews Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments
CNS & Neurological Disorders - Drug Targets Pregnancy Complicated by the Most Frequent Forms of Maturity Onset Diabetes of the Young: A Narrative Review on Its Pharmacological Implications
Current Reviews in Clinical and Experimental Pharmacology Diabetes and its Complications - Contemporary Treatment and Potential Side Effects of Drugs to Treat Diabetes
Current Drug Safety Cardio-Protective Effects of Sodium-Glucose Co-Transporter 2 Inhibitors: Focus on Heart Failure
Current Pharmaceutical Design Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Recent Patents on Drug Delivery & Formulation Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies
Current Drug Metabolism ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Current Medicinal Chemistry Hydrogels: A Journey from Diapers to Gene Delivery
Mini-Reviews in Medicinal Chemistry Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
Current Diabetes Reviews Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a<sup>-/-</sup> Model
Current Pharmaceutical Design SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
Current Clinical Pharmacology Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Exercise and Nutraceuticals: Eminent Approach for Diabetic Neuropathy
Current Molecular Pharmacology Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry The Impact of a New Best Practice Advisory on the Management of Diabetic Ketoacidosis
Current Diabetes Reviews MR Imaging of Pancreatic Islets: Tracking Isolation, Transplantation and Function
Current Pharmaceutical Design